FDA Seizes Thousands of Counterfeit Ozempic Units

Ongoing Testing by FDA and Novo Nordisk to Determine Safety of Seized Drugs

Counterfeit versions of the popular diabetes drug Ozempic have infiltrated the U.S. drug supply chain, with the FDA seizing thousands of units.
The FDA and Novo Nordisk, the maker of Ozempic, are currently testing the seized counterfeit drugs to determine their identity, quality, and safety.
Five illnesses have been linked to the counterfeit Ozempic, but none have been serious. The symptoms were similar to common side effects of Ozempic, like nausea and stomach pain.
The counterfeit Ozempic products come with counterfeit needles, pen labels, cartons, fact sheets, and needles, posing an infection risk to consumers.
The FDA is advising retail pharmacies to buy authentic Ozempic only through authorized distributors and for patients to get it only through state-licensed pharmacies.